Geneos Wealth Management’s Innovator Lunt Low Vol/High Beta Tactical ETF LVHB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,521
Closed -$438K 2938
2021
Q3
$438K Sell
12,521
-2,858
-19% -$100K 0.02% 604
2021
Q2
$536K Sell
15,379
-150
-1% -$5.23K 0.02% 547
2021
Q1
$534K Hold
15,529
0.01% 619
2020
Q4
$528K Hold
15,529
0.02% 525
2020
Q3
$490K Sell
15,529
-479,557
-97% -$14.9M 0.03% 436
2020
Q2
$14.6M Sell
495,086
-174,934
-26% -$4.95M 0.81% 22
2020
Q1
$16.9M Buy
670,020
+27,010
+4% +$924K 1.13% 14
2019
Q4
$25M Buy
643,010
+20,537
+3% +$757K 1.33% 9
2019
Q3
$22.9M Buy
622,473
+3,780
+0.6% +$136K 1.37% 10
2019
Q2
$21.7M Sell
618,693
-9,045
-1% -$310K 1.34% 9
2019
Q1
$21M Sell
627,738
-101,103
-14% -$3.23M 1.39% 8
2018
Q4
$21.5M Sell
728,841
-11,317
-2% -$350K 1.59% 6
2018
Q3
$23.3M Sell
740,158
-834,557
-53% -$26.2M 1.55% 5
2018
Q2
$47.8M Buy
+1,574,715
New +$49.1M 3.72% 2

Geneos Wealth Management's LVHB Position: Q4 2021 in Review

Geneos Wealth Management sold out of Innovator Lunt Low Vol/High Beta Tactical ETF (LVHB) in Q4 2021, closing a stake of 12,521 shares — an estimated $438K sold.

Geneos Wealth Management first reported a position in LVHB in Q2 2018 and held it in 14 quarters. The position peaked at $47.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold LVHB as of Q4 2021.

  • Geneos Wealth Management reported no remaining Innovator Lunt Low Vol/High Beta Tactical ETF position as of Q4 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 12,521 Innovator Lunt Low Vol/High Beta Tactical ETF shares in Q4 2021, an estimated $438K.
  • Geneos Wealth Management first reported a position in Innovator Lunt Low Vol/High Beta Tactical ETF in Q2 2018 and held it in 14 quarters.
  • Geneos Wealth Management's Innovator Lunt Low Vol/High Beta Tactical ETF position peaked at $47.8M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Innovator Lunt Low Vol/High Beta Tactical ETF as of Q4 2021.

Based on Geneos Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.